SPC331
Avapritinib eða lyfjafræðilega viðunandi sölt þar af
:
Veitt:
24.3.2021:
15.4.2021:
15.10.2023
:
24.9.2035:
AYVAKYT
24.3.2021
15.4.2021
15.10.2023
24.9.2035
:
EU1/20/1473/001; EU1/20/1473/002; EU1/20/1473/003:
24.9.2020
:
EU1/20/1473:
24.9.2020
:
Blueprint Medicines Corporation:
45 Sidney Street, Cambridge, MA US
:
Budde Schou A/S:
Dronningens Tværgade 30, 1302 Copenhagen K